Leslie J Ng
Overview
Explore the profile of Leslie J Ng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters J, Force L, Ng L, Li H, Aoki K, Taguchi N, et al.
Respir Investig
. 2024 Jan;
62(2):192-199.
PMID: 38185020
Background: To evaluate the occurrence of adverse drug reactions (ADRs) and to assess mortality and health status in participants receiving remdesivir in real-world settings in Japan. Methods: This postmarketing surveillance...
2.
Hige S, Aoki K, Nakamoto D, Flaherty J, Botros I, Mizutani H, et al.
J Viral Hepat
. 2024 Jan;
31(4):165-175.
PMID: 38163911
Tenofovir alafenamide (TAF), a prodrug of tenofovir, delivers high levels of active drug to hepatocytes and is given in a lower dose than tenofovir disoproxil fumarate (TDF). TAF reduces viral...
3.
Mita E, Liu L, Shing D, Force L, Aoki K, Nakamoto D, et al.
Intern Med
. 2022 Sep;
62(10):1405-1414.
PMID: 36047126
Objectives Real-world evidence on the safety and effectiveness of direct-acting antivirals in patients infected with chronic hepatitis C virus (HCV) genotypes (GTs) 3, 4, 5, or 6 in Japan is...
4.
Mizokami M, Liu L, Fujiyama N, Littman M, Yuan J, Sekiya T, et al.
J Viral Hepat
. 2020 Sep;
28(1):129-141.
PMID: 32869924
As patients with chronic hepatitis C virus (HCV) tend to be older and/or have advanced liver disease in Japan, real-world data are needed to evaluate safe and effective treatment options....
5.
Robinson B, Zhang J, Morgenstern H, Bradbury B, Ng L, McCullough K, et al.
Kidney Int
. 2013 Jun;
85(1):158-65.
PMID: 23802192
Mortality rates for maintenance hemodialysis patients are much higher than the general population and are even greater soon after starting dialysis. Here we analyzed mortality patterns in 86,886 patients in...
6.
Freburger J, Ng L, Bradbury B, Kshirsagar A, Brookhart M
Am J Med
. 2012 Sep;
125(9):906-14.e9.
PMID: 22938926
Background: Erythropoiesis-stimulating agents and adjuvant intravenous iron have been the primary treatment for anemia in chronic kidney disease. Recent clinical and policy-related events have challenged this traditional paradigm, particularly in...
7.
Ng L, Chen F, Pisoni R, Krishnan M, Mapes D, Keen M, et al.
Nephrol Dial Transplant
. 2011 Mar;
26(11):3659-66.
PMID: 21372255
Background: The excess morbidity and mortality related to catheter utilization at and immediately following dialysis initiation may simply be a proxy for poor prognosis. We examined hospitalization burden related to...
8.
Park S, Chang S, Cai L, Cordon-Cardo C, Ding B, Greenland S, et al.
Cancer Epidemiol Biomarkers Prev
. 2008 Nov;
17(11):3193-202.
PMID: 18990762
Recent genome-wide association studies identified key single nucleotide polymorphisms (SNPs) in the 8q24 region to be associated with prostate cancer. 8q24 SNPs have also been associated with colorectal cancer, suggesting...